Affymetrix, CRI, Third Wave, LabCorp, Bio-Rad, Ciphergen, Qiagen, Digene, Invitrogen, Biocon, Roche, Eppendorf | GenomeWeb
Affymetrix’s CSL, DOCRO Ink IVD Alliance
Affymetrix’s Clinical Services Laboratory and in vitro diagnostics contract research company DOCRO have formed a partnership to help pharmaceutical companies, IVD makers, and other customers move their products toward clearance by the US Food and Drug Administration, Affymetrix said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.